EP1954800A4 - Zusammensetzung und verwendung von phyto-percolat zur behandlung von einer krankheit - Google Patents

Zusammensetzung und verwendung von phyto-percolat zur behandlung von einer krankheit

Info

Publication number
EP1954800A4
EP1954800A4 EP06838974A EP06838974A EP1954800A4 EP 1954800 A4 EP1954800 A4 EP 1954800A4 EP 06838974 A EP06838974 A EP 06838974A EP 06838974 A EP06838974 A EP 06838974A EP 1954800 A4 EP1954800 A4 EP 1954800A4
Authority
EP
European Patent Office
Prior art keywords
phyto
percolate
disease
treatment
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06838974A
Other languages
English (en)
French (fr)
Other versions
EP1954800A2 (de
Inventor
Tiffany Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zivo Bioscience Inc
Original Assignee
Health Enhancement Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Health Enhancement Products Inc filed Critical Health Enhancement Products Inc
Publication of EP1954800A2 publication Critical patent/EP1954800A2/de
Publication of EP1954800A4 publication Critical patent/EP1954800A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Virology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • AIDS & HIV (AREA)
EP06838974A 2005-12-02 2006-12-04 Zusammensetzung und verwendung von phyto-percolat zur behandlung von einer krankheit Withdrawn EP1954800A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74177405P 2005-12-02 2005-12-02
PCT/US2006/046320 WO2007065024A2 (en) 2005-12-02 2006-12-04 Composition and use of phyto-percolate for treatment of disease

Publications (2)

Publication Number Publication Date
EP1954800A2 EP1954800A2 (de) 2008-08-13
EP1954800A4 true EP1954800A4 (de) 2010-03-03

Family

ID=38092904

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06838974A Withdrawn EP1954800A4 (de) 2005-12-02 2006-12-04 Zusammensetzung und verwendung von phyto-percolat zur behandlung von einer krankheit

Country Status (5)

Country Link
EP (1) EP1954800A4 (de)
JP (1) JP2009518312A (de)
AU (1) AU2006320264A1 (de)
CA (1) CA2631773C (de)
WO (1) WO2007065024A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7807622B2 (en) 2004-04-23 2010-10-05 Health Enhancement Products, Inc. Composition and use of phyto-percolate for treatment of disease
US10166270B2 (en) 2004-04-23 2019-01-01 Zivo Bioscience, Inc. Composition and method for affecting cytokines and NF-κB
US8586053B2 (en) 2005-09-21 2013-11-19 Health Enhancement Products, Inc. Composition and use of phyto-percolate for treatment of disease
JP2013510905A (ja) * 2009-11-16 2013-03-28 ヘルス エンハンスメント プロダクツ インク サイトカイン及びｎｆ−ｋｂに影響を与える組成物及び方法
JP2013520444A (ja) 2010-02-22 2013-06-06 ヘルス エンハンスメント プロダクツ インコーポレイテッド 高コレステロール血症を処置するための薬剤及び機序
AU2014252808A1 (en) * 2013-04-09 2015-11-12 Cresset Biomolecular Discovery Ltd The treatment of inflammatory disorders
WO2014201372A1 (en) 2013-06-13 2014-12-18 Health Enhancement Products, Inc. Compounds and methods for affecting cytokines
EP3258948B1 (de) 2015-02-16 2023-12-06 Zivo Bioscience, Inc. Anti-entzündliche und immunomodulatorische zusammensetzungen, enthaltend klebsormidium und verwendungen davon
MX2018009819A (es) 2016-02-16 2019-02-20 Zivo Bioscience Inc Soporte nutricional para animales mediante la administracion de un suplemento derivado de algas.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005112987A2 (en) * 2004-04-23 2005-12-01 Health Enhancement Products, Inc. Method of preparation and use of fibrinolytic enzymes in the treatment of disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1307213B1 (de) * 2000-08-10 2004-04-28 Ocean Nutrition Canada Ltd. Chlorella zubereitungen mit immunmodulatorischen eigenschaften

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005112987A2 (en) * 2004-04-23 2005-12-01 Health Enhancement Products, Inc. Method of preparation and use of fibrinolytic enzymes in the treatment of disease

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
"Research indicates ProAlgaZyme may decrease risk of stroke or heart attack", INTERNET CITATION, 20 January 2004 (2004-01-20), XP002538927 *
OBEN JULIUS ET AL: "The effects of ProAlgaZyme novel algae infusion on metabolic syndrome and markers of cardiovascular health", LIPIDS IN HEALTH AND DISEASE, BIOMED CENTRAL, LONDON, GB, vol. 6, no. 1, 5 September 2007 (2007-09-05), pages 20, XP021029930, ISSN: 1476-511X *
WONKEUK KIM ET AL: "Purification and Characterization of a Fibrinolytic Enzyme Produced from Bacillus sp. strain CK 11-4 Screened from Chungkook-Jang", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 62, no. 7, 1 July 1996 (1996-07-01), pages 2482 - 2488, XP007908743, ISSN: 0099-2240 *

Also Published As

Publication number Publication date
JP2009518312A (ja) 2009-05-07
CA2631773A1 (en) 2007-06-07
AU2006320264A1 (en) 2007-06-07
CA2631773C (en) 2022-04-26
WO2007065024A3 (en) 2008-01-10
WO2007065024A2 (en) 2007-06-07
EP1954800A2 (de) 2008-08-13

Similar Documents

Publication Publication Date Title
EP2007385A4 (de) Kardiovaskuläre zusammensetzung und ihre verwendung zur behandlung von morbus alzheimer
EP1928453A4 (de) Verfahren und zusammensetzungen zur prävention und behandlung von nierenerkrankungen
IL186616A (en) Spyro-oxa-indoles and their use as drugs
IL185462A0 (en) New pharmaceutical compositions useful in the treatment of pain
EP1968607A4 (de) Behandlung von krebs und anderen erkrankungen
EP1931390A4 (de) Zusammensetzungen und verfahren zur behandlung von autoimmunkrankheit
IL185309A0 (en) Isoqunoline compounds and methods of use thereof
EP1954800A4 (de) Zusammensetzung und verwendung von phyto-percolat zur behandlung von einer krankheit
HK1131553A1 (zh) 用於治療皮膚的美容組合物以及用於治療皮膚的方法
ZA200607471B (en) Materials and methods for treatment of allergic disease
EP1928247A4 (de) Zusammensetzung und verwendung von phytopercolat zur behandlung von krankheiten
IL187405A0 (en) Methods and compositions for the treatment of pain
EP1933853A4 (de) Behandlung von gewebedisruption und zusammensetzung zur anwendung dafür
EP1930017A4 (de) Zusammensetzung zur prävention und behandlung von krankheiten von erwachsenen
IL186022A0 (en) Dermatological compositions and salts for the treatment of dermatological diseases
EP2010215A4 (de) Verfahren und zusammensetzungen zur behandlung von morbus crohn
EP2007790A4 (de) Verbindungen und verfahren zur behandlung von schmerzen
HU0500145D0 (en) Composition for the treatment of oral diseases
GB0620695D0 (en) Composition and methods for the treatment of nurdegenerative disease
EP1865952A4 (de) Histaminhaltige zusammensetzung zur behandlung von allergischen erkrankungen
GB0504657D0 (en) Compositions and methods of treatment
EP1797430A4 (de) Verfahren und zusammensetzungen zur diagnose und behandlung von krebs
EP1962882A4 (de) Zusammensetzungen und verfahren zur behandlung von diabetes
IL185900A0 (en) Compositions and methods for the diagnosis and treatment of tumor
EP1850827A4 (de) Zusammensetzung zur behandlung und vorbeugung einer periodontalen erkrankung sowie verwendungsverfahren

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080617

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: HEALTH ENHANCEMENT PRODUCTS, INC.

A4 Supplementary search report drawn up and despatched

Effective date: 20100201

RIC1 Information provided on ipc code assigned before grant

Ipc: A01N 65/00 20090101AFI20100126BHEP

17Q First examination report despatched

Effective date: 20100223

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20100701